International AAMDSIF Bone Marrow Failure Disease Scientific Symposium (AAMDSIF BMF) 2024 PNH

International AAMDSIF Bone Marrow Failure Disease Scientific Symposium (AAMDSIF BMF) 2024

Efficacy and Safety Is Maintained in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan for Up to 3 Years

Access Resources

Human Factors Validation Study for a Wearable, Single-Use Injector and a User Experience Survey of Complement Inhibitor-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria

Access Resources

Improvement in Iron Overload With Pegcetacoplan Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With Eculizumab

Access Resources

Back to Conference Resources

PNH Congress Presentations

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

International AAMDSIF Bone Marrow Failure Disease Scientific Symposium (AAMDSIF BMF) 2024

Back to Conference Resources

Report an Adverse Event or Product complaint

Ask a Medical Question

Connect with an MSL

Landing